Skip to main content
. 2023 Mar 20;2023(3):CD008721. doi: 10.1002/14651858.CD008721.pub3

4.1. Analysis.

4.1

Comparison 4: Analysis stratified by anti‐VEGF plus PRP versus anti‐VEGF alone, both compared with PRP, Outcome 1: Visual acuity comparing anti‐VEGFs plus PRP versus anti‐VEGF alone